First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial - Alex De Caluwe; Emanuela Romano; Philip Poortmans; Andrea Gombos; Elisa Agostinetto; Guilherme Nader Marta; Zoe Denis; Stylianos Drisis; Christophe Vandekerkhove; Antoine Desmet; Catherine Philippson; Ligia Craciun; et al. (Journal for ImmunoTherapy of Cancer, 2023)